RUSSIAN OFFENSIVE CAMPAIGN ASSESSMENT, SEPTEMBER 29
The big news last night was the announcement of a positive readout in Eisai and Biogen’s trial of lecanemab, another attempt an an anti-amyloid antibody for Alzheimer’s therapy. It was big news because positive results have been very rare indeed in this area, and there is a barrage of headlines this morning.
30 ex-FBI agents stand up to support whistleblower who exposed agency’s political bias
Sweden Finds A Fourth Leak In Nord Stream Pipelines
Iran Crisis Update, September 28
France: Strike disrupts energy sector, schools, transport